We are pleased to announce that Cambridge Bioscience has partnered with AssayQuant Technologies, a trusted supplier of robust, easy-to-use assays to enable drug discovery research
Founded in 2015, AssayQuant Technologies offers 400 unique continuous enzyme and inhibitor assays to accelerate drug developement and efficacy, supporting faster and more effective lead identification, characterisation, profiling and optimisation.
Cambridge Bioscience are delighted to distribute AssayQuant Technologies products in the UK and Ireland.
Learn more about AssayQuant Technologies or contact our AssayQuant Technologies specialists to see how their technologies can accelerate your discovery.
Published
03 Jul 2024